HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Elke M G J de Jong Selected Research
Elke M G J de Jong Research Topics
Disease
46
Psoriasis (Pustulosis Palmaris et Plantaris)
11/2022 - 08/2004
6
Inflammation (Inflammations)
10/2021 - 02/2004
6
Localized Scleroderma (Morphea)
01/2021 - 12/2008
4
Neoplasms (Cancer)
01/2022 - 05/2003
4
Psoriatic Arthritis
01/2021 - 03/2010
4
Rheumatoid Arthritis
01/2017 - 01/2005
3
Eosinophilic Fasciitis
01/2021 - 12/2008
3
Infections
12/2014 - 01/2005
2
Candidiasis (Moniliasis)
11/2022 - 02/2022
2
Rosacea (Acne Rosacea)
02/2022 - 11/2020
2
Dermatomyositis (Dermatopolymyositis)
01/2021 - 01/2005
2
Crohn Disease (Crohn's Disease)
01/2016 - 01/2011
2
Fibrosis (Cirrhosis)
08/2013 - 06/2007
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2009 - 02/2004
2
Eczema
01/2009 - 01/2005
2
Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2005 - 05/2003
2
Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
08/2004 - 08/2004
1
Cutaneous Candidiasis
02/2022
1
Autoimmune Diseases (Autoimmune Disease)
01/2021
1
Lymphopenia (Lymphocytopenia)
11/2020
1
Arthritis (Polyarthritis)
01/2020
1
Herpes Zoster
09/2019
1
Cardiovascular Diseases (Cardiovascular Disease)
12/2014
1
Skin Neoplasms (Skin Cancer)
12/2014
1
Disease Progression
10/2014
1
Drug-Related Side Effects and Adverse Reactions
08/2013
1
Ankylosing Spondylitis
01/2011
Drug/Important Bio-Agent (IBA)
13
Adalimumab (Humira)
FDA Link
08/2022 - 01/2008
13
Methotrexate (Mexate)
FDA Link
Generic
01/2022 - 06/2007
10
Biological Products
IBA
10/2021 - 01/2008
8
Etanercept (Enbrel)
FDA Link
08/2022 - 01/2013
8
Ustekinumab (CNTO 1275)
FDA Link
08/2022 - 05/2016
7
Pharmaceutical Preparations
IBA
08/2022 - 01/2005
6
Infliximab (Remicade)
FDA Link
11/2020 - 01/2009
5
Biomarkers (Surrogate Marker)
IBA
01/2021 - 01/2009
4
Interleukin-17 (Interleukin 17)
IBA
11/2022 - 01/2021
4
Antibodies
IBA
08/2022 - 05/2003
4
Interleukins
IBA
02/2022 - 07/2018
4
Acitretin
FDA Link
11/2020 - 05/2003
3
secukinumab
IBA
10/2021 - 07/2018
3
Proteins (Proteins, Gene)
FDA Link
01/2021 - 01/2009
3
Retinoids
IBA
08/2004 - 01/2002
2
Interleukin-12 (IL 12)
IBA
11/2022 - 10/2021
2
Ivermectin (Mectizan)
FDA Link
02/2022 - 11/2020
2
Proteome
IBA
02/2022 - 08/2013
2
Interleukin-23 (Interleukin 23)
IBA
10/2021 - 01/2021
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2021 - 01/2021
2
beta-Defensins
IBA
01/2021 - 01/2009
2
Fumarates
IBA
11/2020 - 05/2016
2
Cyclosporine (Ciclosporin)
FDA Link
Generic
11/2020 - 05/2016
2
HLA-C Antigens (HLA-C)
IBA
01/2019 - 11/2014
2
Cytokines
IBA
10/2014 - 01/2009
2
DNA (Deoxyribonucleic Acid)
IBA
01/2005 - 05/2003
2
Bexarotene (LGD1069)
FDA Link
08/2004 - 08/2004
2
Transglutaminases
IBA
08/2004 - 02/2004
1
risankizumab
IBA
10/2021
1
tildrakizumab
IBA
10/2021
1
guselkumab
IBA
10/2021
1
ixekizumab
IBA
10/2021
1
brodalumab
IBA
10/2021
1
Angiopoietins
IBA
01/2021
1
Kallikreins (Kallikrein)
IBA
01/2021
1
Galectin 1 (LGALS1)
IBA
01/2021
1
Ligands
IBA
01/2021
1
Interleukin-18 (Interleukin 18)
IBA
01/2021
1
CXC Chemokines
IBA
01/2021
1
Membrane Proteins (Integral Membrane Proteins)
IBA
01/2021
1
CC Chemokines
IBA
01/2021
1
Thrombospondin 1
IBA
01/2021
1
Fetuins
IBA
01/2021
1
Type II Tumor Necrosis Factor Receptors
IBA
01/2021
1
Genetic Markers (Genetic Marker)
IBA
01/2021
1
Fibronectins (Fibronectin)
IBA
01/2021
1
Interferons
IBA
01/2021
1
TIE Receptors (TIE Receptor Tyrosine Kinases)
IBA
01/2021
1
Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)
IBA
01/2021
1
Peptide Hydrolases (Proteases)
FDA Link
01/2021
1
Blood Proteins (Serum Proteins)
IBA
01/2021
1
Interleukin-8 (Interleukin 8)
IBA
01/2021
1
Interleukin-4 (Interleukin 4)
IBA
01/2021
1
Interleukin-22 (IL-22)
IBA
01/2021
1
Steroids
IBA
01/2018
1
C-Reactive Protein
IBA
09/2017
1
Mycophenolic Acid (Cellcept)
FDA Link
Generic
05/2016
1
omega-Chloroacetophenone (Mace)
IBA
12/2014
1
Interleukin-2 (IL2)
IBA
10/2014
1
Transferrin (beta 2 Transferrin)
IBA
08/2013
1
Haptoglobins
IBA
08/2013
1
Cadherins (E-Cadherin)
IBA
08/2013
1
procollagen Type III-N-terminal peptide (PIIP)
IBA
08/2013
1
inter-alpha-inhibitor
IBA
08/2013
1
Collagen Type III (Type III Collagen)
IBA
08/2013
Therapy/Procedure
19
Therapeutics
11/2022 - 08/2004
7
Biological Therapy
01/2020 - 03/2010
6
Drug Tapering
08/2022 - 01/2017
2
Lasers (Laser)
01/2022 - 11/2008
2
Phototherapy (Light Therapy)
01/2018 - 12/2008
1
Activities of Daily Living (ADL)
01/2022
1
Polypharmacy
01/2022
1
Duration of Therapy
04/2019